Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have earned an average rating of “Moderate Buy” from the fourteen brokerages that are presently covering the company, MarketBeat reports. Six analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $30.0769.

A number of research analysts have issued reports on the company. Weiss Ratings lowered Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Zacks Research raised Option Care Health from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. UBS Group restated a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. JPMorgan Chase & Co. cut their price objective on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Finally, TD Cowen reduced their price objective on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a report on Friday, May 1st.

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $21.67 on Wednesday. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. The stock has a 50 day simple moving average of $21.23 and a 200-day simple moving average of $27.32. The company has a market cap of $3.40 billion, a PE ratio of 16.80, a P/E/G ratio of 1.21 and a beta of 0.65. Option Care Health has a 12-month low of $18.01 and a 12-month high of $36.80.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.39 billion. During the same period in the prior year, the company posted $0.40 EPS. The business’s revenue for the quarter was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, equities research analysts forecast that Option Care Health will post 1.64 EPS for the current year.

Insiders Place Their Bets

In related news, CEO John Charles Rademacher acquired 12,500 shares of the firm’s stock in a transaction dated Monday, May 4th. The stock was acquired at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the acquisition, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. The trade was a 1.83% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Timothy P. Sullivan acquired 24,154 shares of the firm’s stock in a transaction dated Thursday, May 7th. The stock was bought at an average price of $20.69 per share, with a total value of $499,746.26. Following the completion of the acquisition, the director directly owned 73,383 shares of the company’s stock, valued at approximately $1,518,294.27. This represents a 49.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders have purchased 73,264 shares of company stock worth $1,548,316. 1.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Option Care Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Durable Capital Partners LP lifted its position in Option Care Health by 134.2% in the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the period. Southpoint Capital Advisors LP acquired a new position in shares of Option Care Health during the 4th quarter valued at $95,580,000. Sumitomo Mitsui Trust Group Inc. acquired a new position in shares of Option Care Health during the 1st quarter valued at $70,287,000. Norges Bank bought a new stake in shares of Option Care Health in the 4th quarter worth $61,787,000. Finally, Van Berkom & Associates Inc. bought a new stake in shares of Option Care Health in the 1st quarter worth $42,739,000. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.